← Find more feeds

ncbi.nlm.nih.gov

New Releases from NCBI Bookshelf

Get the latest updates from New Releases from NCBI Bookshelf directly as they happen.

Follow now < 10 followers

Latest posts

Last updated about 23 hours ago

Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and over.

2 days ago

Read full

12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites.

2 days ago

Read full

Capivasertib with fulvestrant for treating hormone receptor-positive HER2-negative advanced breast cancer after endocrine treatment.

2 days ago

Read full

Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphoma.

2 days ago

Read full

Dostarlimab with platinum-based chemotherapy for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency.

2 days ago

Read full

Molnupiravir for treating COVID-19.

2 days ago

Read full

Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer.

2 days ago

Read full

Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphoma after first-line chemoimmunotherapy when a stem cell transplant is suitable.

2 days ago

Read full

Nivolumab plus ipilimumab for untreated unresectable or metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency.

2 days ago

Read full

Blinatumomab with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive minimal residual disease-negative B-cell precursor acute lymphoblastic leukaemia.

2 days ago

Read full

Bayesian Filter Design for Computational Medicine: A State-Space Estimation Framework [Internet].

2 days ago

Read full

Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy (terminated appraisal).

2 days ago

Read full

Or log in

Everything you care about in one place

New Releases from NCBI Bookshelf

Latest posts

Ruxolitinib for treating acute graft versus host disease that responds inadequately to corticosteroids in people 12 years and over.

12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites.

Capivasertib with fulvestrant for treating hormone receptor-positive HER2-negative advanced breast cancer after endocrine treatment.

Brentuximab vedotin in combination for untreated stage 3 or 4 CD30-positive Hodgkin lymphoma.

Dostarlimab with platinum-based chemotherapy for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency.

Molnupiravir for treating COVID-19.

Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer.

Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphoma after first-line chemoimmunotherapy when a stem cell transplant is suitable.

Nivolumab plus ipilimumab for untreated unresectable or metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency.

Blinatumomab with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive minimal residual disease-negative B-cell precursor acute lymphoblastic leukaemia.

Bayesian Filter Design for Computational Medicine: A State-Space Estimation Framework [Internet].

Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy (terminated appraisal).

Try Feeder for free